Skip to main content
Log in

Immunosuppressant therapy of idiopathic thrombocytopenic purpura

  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Ahn YS, Harrington WJ (1977) Treatment of idiopathic thrombocytopenic purpura. Annu Rev Med 28: 299

    PubMed  Google Scholar 

  2. Ahn YS, Harrington WJ (1980) Clinical use of macrophage inhibitors. Adv Intern Med 25: 453

    PubMed  Google Scholar 

  3. Ahn YS, Harrington WJ, Seelman RC, Eytel C (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291: 376

    PubMed  Google Scholar 

  4. Ahn YS, Byrnes JJ, Harrington WJ, Cayer ML, Smith DS, Brunskill DE, Pall LM (1978) The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. N Engl J Med 298:1101

    PubMed  Google Scholar 

  5. Ahn YS, Harrington WJ, Byrnes JJ, Pestana JB (1978) Slow infusion vinca alkaloids in the treatment of refractory ITP. Clin Res 26: 795a

    Google Scholar 

  6. Ahn YS, Harrington WJ, Mylvaganam R, Allan LM, Pall LM (to be published) Slow infusion of vinca alkaloids in treatment of idiopathic thrombocytopenic purpura. Ann Intern Med

  7. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) The use of danazol in idiopathic thrombocytopenia purpura. N Engl J Med

  8. Ahn YS, Harrington WJ, Mylvaganam R, Chua L, Otoya J, Pall LM. Danazol therapy restores helper/suppressor (T4/T8) ratios in patients with idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia Blood 62 (suppl) 1983 (in press)

  9. Bierling P, Farcet JP, Dvedari N (1982) Gammaglobulin for idiopathic thrombocytopenic purpura. N Engl J Med 307: 1150

    PubMed  Google Scholar 

  10. Bouroncle BA, Doan CA (1966) Refractory idiopathic thrombocytopenic purpura treated with Imuran. N Engl J Med 275: 630

    PubMed  Google Scholar 

  11. Branda RE, Tate DY, McCullough JJ, Jacob HS (1978) Plasma exchange in the treatment of fulminant (autoimmune) thrombocytopenic purpura. Lancet 1: 688

    PubMed  Google Scholar 

  12. Brennan MF, Rappaport JM, Moloney WC, Wilson RE et al. (1975) Correlation between response to corticosteroids and splenectomy for adult idiopathic thrombocytopenic purpura. Am J Surg 129:490

    PubMed  Google Scholar 

  13. Broome CV, Facklam RR, Fraser DW (1980) Pneumococcal disease after pneumococcal vaccination: alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 303: 549

    PubMed  Google Scholar 

  14. Watson-Williams EJ, Macpherson AIS, Davidson S (1958) Treatment of idiopathic thrombocytopenic purpura. Lancet 275: 221

    Google Scholar 

  15. Carpenter AF, Wintrobe MM, Fuller EA, Haut A, Cartwright G (1959) Treatment of idiopathic thrombocytopenic purpura. JAMA 171: 1911

    PubMed  Google Scholar 

  16. Cohen P, Gardner FH (1961) Thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura. N Engl J Med 265: 611

    PubMed  Google Scholar 

  17. Defino SM, Lachant NA, Kirshner JJ, Gottlieb AJ (1980) Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med 69: 430

    PubMed  Google Scholar 

  18. Doan CA, Bouroncle BA, Wiseman BK (1960) Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 53: 861

    Google Scholar 

  19. Fehr J, Hoffman V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high dose intravenous gammaglobulin. N Engl J Med 306: 1254

    PubMed  Google Scholar 

  20. Finch SC, Castro O, Cooper M, Covey W, Erichson R, McPhedran P (1974) Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med 56: 4

    PubMed  Google Scholar 

  21. Finland M (1961) Serious infections in splenectomized children. Pediatrics 27: 689

    PubMed  Google Scholar 

  22. Harker LA (1970) Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol (1916) 19: 95

    PubMed  Google Scholar 

  23. Harrington WJ, Ahn YS. Unpublished observations

  24. Harrington WJ, Arimura G (1961) Immune reactions of platelets. Henry Ford Hosp. Symp. Blood platelets. Little Brown, Boston, p 659

    Google Scholar 

  25. Harrington WJ, Halloran MJ (1960) Studies on steroid binding by mammaliam platelets. Proc VIII Intern Congr Hematol 1960, p 1750

  26. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38: 1

    PubMed  Google Scholar 

  27. Harrington WJ, Sprague CC, Minnich V, Moore CV, Ahlvin R, Dubach R (1953) Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 38: 433

    PubMed  Google Scholar 

  28. Harrington WJ, Minnich V, Arimura G (1956) The autoimmune thrombocytopenias. Prog Hematol 1: 166

    PubMed  Google Scholar 

  29. Harrington WJ, Ahn YS, So AG, Ayub J, Simon S, Pall LM (1982) Danazol therapy of autoimmune thrombocytopenias. Blood 60: 186a

    Google Scholar 

  30. Imbach P, Barandum S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, Rossi E, Schöni M, Vest M, Wagner HP (1981) High dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1: 1228

    PubMed  Google Scholar 

  31. Junghans RP, Ahn YS, Mylvaganam R (1983) High dose intravenous gammaglobulin to suppress alloimmune destruction of donor platelets. Clin Res 31: 482A

    Google Scholar 

  32. Karpatkin S (1980) Autoimmune thrombocytopenic purpura. Blood 56: 329

    PubMed  Google Scholar 

  33. Kaznelson P (1916) Verschwinden der hämorrhagischen Diathese bei einem Falle von „essentieller Thrombopenie” (Frank) nach Milzextirpation. Splenogene thrombolytische purpura. Wien Klin Wochenschr 29: 1451

    Google Scholar 

  34. Laros RK, Penner JA (1971) “Refractory” thrombocytopenia purpura treated successfully with cyclophosphamide. JAMA 215: 445

    PubMed  Google Scholar 

  35. Marder VJ, Nusbacher J, Anderson FW (1981) One year follow-up of plasma exchange therapy in 14 patients with thrombocytopenic purpura. Transfusion 21: 291

    PubMed  Google Scholar 

  36. McMillan R (1981) Chronic idiopathic thrombocytopenic purpura. N Engl J Med 304: 1135

    PubMed  Google Scholar 

  37. Melo J, Harrington WJ, Ahn YS, Collin AS (1981) Colchicine therapy of idiopathic thrombocytopenic purpura (ITP). Blood 58 (Suppl 1): 200A

    Google Scholar 

  38. Meyers MC (1961) Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sci 242: 295

    PubMed  Google Scholar 

  39. Michalski JP, McCombs CC, Roubinian JR, Talal N (1983) Effect of androgen therapy on survival and suppressor cell activity in aged NZB/NZW Fl hybrid mice. Clin Exp Immunol 52: 229

    PubMed  Google Scholar 

  40. Mueller-Eckhardt C, Kuenzlen E, Thilo-Korner D, Thilo-Körner, Pralle H (1983) High-dose intravenous immunoglobulin for post-transfusion purpura. N Engl J Med 308: 287

    Google Scholar 

  41. Robson HN, Duthie JJR (1950) Capillary resistance and adrenocortical activity. Br Med J 2: 971

    PubMed  Google Scholar 

  42. Shulman NR, Marder VJ, Weinrach RS (1965) Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic thrombocytopenic purpura: physiologic, serologic, and isotopic studies. Ann NY Acad Sci 124: 499

    PubMed  Google Scholar 

  43. Strother SV, Zuckerman KS, LoBuglio AF (1982) Colchicine therapy of refractory immune thrombocytopenia. Blood 60 (Suppl 1): 193A

    Google Scholar 

  44. Sussman LN (1967) Azathioprine in refractory idiopathic thrombocytopenic purpura. JAMA 202: 259

    PubMed  Google Scholar 

  45. Thompson RC, Moore RA, Hess CE, Wheby MS, Leavell BS (1972) Idiopathic thrombocytopenic purpura: long-term results of treatment and the prognostic significance of response to corticosteroids. Arch Intern Med 132: 380

    Google Scholar 

  46. Verheyden CN, Beart RW, Lifton MD, Phyliky RL (1978) Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc 53: 442

    PubMed  Google Scholar 

  47. Verlin M, Laros RK, Penner J (1976) Treatment of refractory thrombocytopenic purpura with cyclophosphamide. Am J Hematol 1: 97

    PubMed  Google Scholar 

  48. Viala JJ, Dechavanne M, Ville D (1975) Les épreuves radioisotopiques plaquetaires permettent-elles de meilleures indications de la splénectomie au cours du purpura thrombopénique idiopathique chronique? A propos de 50 observations. Lyon Med 234: 419

    Google Scholar 

  49. Weinerman B, Maxwell I, Hryniuk W (1974) Intermittent cyclosphamide treatment of autoimmune thrombocytopenia. Can Med Assoc J 16: 1100

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants # 5R01 AM 25485 and # 5 M01 RR00261, by a Miami VA merit review award (0215-01) as well as by funds provided by the Mary Beth Weiss Research Fund, the Women's Cancer Association, the Steven Andrew de Young Leukemia Foundation, the H. Spencer Lichte Memorial Fund and the Crane Family Fund.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ahn, Y.S., Harrington, W.J. & Mylvaganam, R. Immunosuppressant therapy of idiopathic thrombocytopenic purpura. Springer Semin Immunopathol 7, 35–42 (1984). https://doi.org/10.1007/BF01891778

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01891778

Keywords

Navigation